Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
OCGN	OCUGEN INC	$371.66M	-491.20%	-99.20%	-163.12%	-157.50%	15.30	1.85	100.00%	-1,192.20%	-1,131.02%
DRIO	DARIOHEALTH CORP	$79.39M	-89.60%	-55.40%	-37.79%	-135.80%	0.57	4.55	56.90%	-257.70%	-165.70%
NXL	NEXALIN TECHNOLOGY INC	$18.81M	-209.20%	-186.90%	-148.47%	-250.60%	0.10	10.44	67.60%	-5,063.00%	-5,064.66%
LIMN	LIMINATUS PHARMA INC	$28.96M	N/A	N/A	N/A	N/A	-1.82	0.42	N/A	N/A	N/A
KYMR	KYMERA THERAPEUTICS INC	$4.67B	-33.40%	-28.60%	-28.61%	-33.60%	0.17	7.38	100.00%	-674.80%	-674.04%
IBIO	IBIO INC	$22.80M	-126.90%	-83.10%	-106.36%	-250.50%	0.56	1.59	100.00%	-4,594.30%	-4,541.25%
BIVI	BIOVIE INC	$11.31M	-82.80%	-75.20%	-73.08%	159,129.60%	0.08	15.83	N/A	N/A	N/A
SYRE	SPYRE THERAPEUTICS INC	$1.82B	-31.20%	-26.80%	-32.51%	-35.40%	0.11	10.91	N/A	N/A	N/A
MBX	MBX BIOSCIENCES INC	$1.11B	-29.30%	-28.10%	-20.75%	-42.40%	0.03	32.96	N/A	N/A	N/A
GLTO	GALECTO INC	$35.61M	-130.70%	-111.30%	-195.32%	-1,211.70%	0.34	3.73	N/A	N/A	N/A
AIMD	AINOS INC	$10.29M	-108.30%	-56.90%	-63.96%	-142.60%	1.09	2.88	82.30%	-14,182.70%	-13,453.71%
SRTS	SENSUS HEALTHCARE INC	$70.96M	-5.70%	-5.00%	-9.08%	-14.60%	0.14	7.38	48.00%	-8.40%	-13.13%
INMB	INMUNE BIO INC	$37.75M	-172.00%	-134.50%	-191.87%	1,346.60%	0.31	4.17	100.00%	-99,774.00%	-99,774.00%
LTRN	LANTERN PHARMA INC	$37.80M	-126.00%	-97.40%	-197.36%	-232.80%	0.42	3.33	N/A	N/A	N/A
RAPP	RAPPORT THERAPEUTICS INC	$1.16B	-28.60%	-27.20%	-18.75%	-38.90%	0.05	36.37	N/A	N/A	N/A
TNDM	TANDEM DIABETES CARE INC	$1.26B	-118.80%	-22.30%	-31.71%	-18.80%	5.58	2.44	53.20%	-20.20%	-19.59%
SLXN	SILEXION THERAPEUTICS CORP	$8.88M	-1,666.00%	-331.90%	-267.26%	-838.50%	0.67	3.97	N/A	N/A	N/A
RARE	ULTRAGENYX PHARMACEUTICAL INC	$3.19B	-436.00%	-43.70%	-67.82%	-38.30%	543.90	1.89	84.70%	-91.90%	-91.46%
ELVN	ENLIVEN THERAPEUTICS INC	$1.31B	-24.90%	-24.00%	-20.41%	-34.80%	0.03	32.95	N/A	N/A	N/A
MIRA	MIRA PHARMACEUTICALS INC	$57.79M	-1,677.80%	-1,519.20%	-74.14%	-532.80%	0.01	90.53	N/A	N/A	N/A
QURE	UNIQURE NV	$1.86B	-373.70%	-35.70%	-20.62%	-22.70%	2.88	7.12	88.10%	-1,492.90%	-1,031.34%
SAVA	CASSAVA SCIENCES INC	$133.33M	-95.80%	-75.30%	-129.80%	2,002.20%	0.59	2.27	N/A	N/A	N/A
DSGN	DESIGN THERAPEUTICS INC	$419.82M	-30.60%	-29.20%	-33.62%	-32.80%	0.06	18.71	N/A	N/A	N/A
CGON	CG ONCOLOGY INC	$3.13B	-16.70%	-16.20%	-14.96%	-19.50%	0.03	30.97	100.00%	-15,945.20%	-15,945.17%
OCS	OCULIS HOLDING AG	$1.10B	-81.70%	-61.80%	-77.18%	-150.90%	0.29	4.47	100.00%	-36,145.10%	-35,938.25%
IMRX	IMMUNEERING CORP	$410.02M	-73.50%	-65.00%	-26.99%	-1,472.40%	0.06	24.00	N/A	N/A	N/A
ALEC	ALECTOR INC	$135.35M	-123.00%	-27.50%	-42.18%	-38.10%	4.81	3.76	100.00%	-156.00%	-155.96%
ALLR	ALLARITY THERAPEUTICS INC	$17.25M	-177.40%	-105.00%	-199.54%	432.30%	0.74	2.31	N/A	N/A	N/A
HURA	TUHURA BIOSCIENCES INC	$102.60M	-277.90%	-172.70%	-137.59%	-3,839.60%	0.78	0.83	N/A	N/A	N/A
CRVS	CORVUS PHARMACEUTICALS INC	$654.96M	-25.80%	-20.20%	-20.82%	-28.70%	0.12	8.29	N/A	N/A	N/A
BBNX	BETA BIONICS INC	$1.20B	-46.80%	-27.10%	-25.55%	-32.90%	0.12	10.64	54.50%	-87.90%	-87.89%
SGMT	SAGIMET BIOSCIENCES INC	$252.04M	-39.90%	-38.40%	-45.62%	-70.70%	0.06	17.55	N/A	N/A	N/A
APVO	APTEVO THERAPEUTICS INC	$23.76M	-411.10%	-168.00%	-123.81%	-519.70%	0.55	4.03	N/A	N/A	N/A
LUNG	PULMONX CORP	$61.46M	-77.60%	-37.90%	-45.97%	-50.10%	1.30	4.86	73.30%	-61.90%	-57.87%
STOK	STOKE THERAPEUTICS INC	$1.51B	13.30%	11.40%	8.62%	16.40%	0.17	6.53	100.00%	19.70%	13.35%
OM	OUTSET MEDICAL INC	$88.95M	-71.10%	-30.70%	-29.54%	-23.70%	0.95	7.09	37.70%	-73.10%	-59.00%
BGMS	BIO GREEN MED SOLUTION INC	$2.93M	-724.50%	-146.00%	-149.63%	212.50%	0.21	5.77	100.00%	-64,280.00%	-54,480.00%
GERN	GERON CORP	$714.96M	-30.30%	-14.00%	-9.57%	-6.90%	1.28	5.96	97.70%	-43.60%	-25.04%
GOSS	GOSSAMER BIO INC	$627.25M	N/A	-59.70%	-100.61%	-38.50%	-3.54	3.28	100.00%	-354.50%	-335.05%
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$187.25M	-55.20%	-49.90%	-42.88%	-210.80%	0.09	9.89	34.30%	-963.40%	-963.38%
ECOR	ELECTROCORE INC	$44.78M	-474.00%	-78.10%	-150.68%	-148.50%	-20.96	1.43	86.00%	-47.50%	-46.82%
VNDA	VANDA PHARMACEUTICALS INC	$257.07M	-16.80%	-13.40%	-22.17%	-33.30%	0.29	3.12	94.40%	-39.70%	-50.52%
VYGR	VOYAGER THERAPEUTICS INC	$218.51M	-48.90%	-37.40%	-49.86%	-45.70%	0.31	6.19	100.00%	-404.80%	-402.55%
KPTI	KARYOPHARM THERAPEUTICS INC	$96.85M	N/A	-101.10%	-883.59%	-45.00%	-1.36	1.03	95.90%	-87.40%	-56.26%
ABOS	ACUMEN PHARMACEUTICALS INC	$104.79M	-97.40%	-70.40%	-107.41%	-81.60%	0.53	6.02	N/A	N/A	N/A
NAUT	NAUTILUS BIOTECHNOLOGY INC	$227.35M	-33.30%	-28.40%	-32.73%	-29.60%	0.19	14.96	N/A	N/A	N/A
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$206.56M	-28.70%	-21.10%	-32.68%	-220.10%	0.26	7.86	100.00%	-68.30%	-83.92%
KRRO	KORRO BIO INC	$57.16M	-68.90%	-45.90%	-60.11%	-49.60%	0.63	6.71	100.00%	-1,199.50%	-1,198.11%
FLGC	FLORA GROWTH CORP	$5.81M	-81.60%	-43.90%	-23.97%	-88.40%	0.14	2.08	17.50%	-32.10%	-31.54%
STIM	NEURONETICS INC	$136.29M	-151.30%	-31.60%	-31.45%	-27.20%	4.17	2.24	50.40%	-34.30%	-28.22%
PTIX	PROTAGENIC THERAPEUTICS INC	$3.89M	N/A	-317.80%	212.72%	408.70%	-2.63	0.41	N/A	N/A	N/A
NGNE	NEUROGENE INC	$352.70M	-29.80%	-27.50%	-31.17%	-38.50%	0.08	18.39	N/A	N/A	N/A
UFPT	UFP TECHNOLOGIES INC	$1.79B	18.00%	10.50%	16.36%	23.30%	0.62	2.41	28.50%	11.20%	15.61%
NEUP	NEUPHORIA THERAPEUTICS INC	$11.29M	-2.00%	-1.50%	-3.44%	41.70%	0.51	3.56	100.00%	-2.40%	-5.35%
SI	SHOULDER INNOVATIONS INC	$302.84M	N/A	N/A	N/A	N/A	0.20	11.09	N/A	N/A	N/A
CARL	CARLSMED INC	$348.63M	N/A	N/A	N/A	N/A	0.26	12.03	N/A	N/A	N/A
SLS	SELLAS LIFE SCIENCES GROUP INC	$203.69M	-95.20%	-75.10%	-56.85%	1,520.90%	0.13	8.28	N/A	N/A	N/A
APGE	APOGEE THERAPEUTICS INC	$4.47B	-39.10%	-36.90%	-42.80%	-46.30%	0.07	15.86	N/A	N/A	N/A
ORIC	ORIC PHARMACEUTICALS INC	$1.19B	-45.30%	-41.80%	-32.91%	-55.20%	0.06	14.65	N/A	N/A	N/A
ACTU	ACTUATE THERAPEUTICS INC	$137.37M	-2,924.50%	-250.70%	-212.50%	311.00%	0.62	2.74	N/A	N/A	N/A
PPCB	PROPANC BIOPHARMA INC	$13.19M	-993.20%	-557.20%	-415.26%	-796.00%	0.41	1.50	N/A	N/A	N/A
PGEN	PRECIGEN INC	$1.72B	-5,766.20%	-311.30%	-176.76%	-238.60%	3.09	4.04	30.30%	-6,750.10%	-3,899.94%
GLPG	GALAPAGOS NV	$2.06B	-16.20%	-11.30%	-14.48%	-14.00%	0.44	8.63	71.10%	-151.40%	-158.11%
BKD	BROOKDALE SENIOR LIVING INC	$2.48B	-267.90%	-5.00%	-1.07%	-0.50%	-894.08	0.84	19.80%	-9.50%	-1.79%
ACXP	ACURX PHARMACEUTICALS INC	$9.57M	-362.10%	-175.30%	-252.13%	359.90%	0.68	2.47	N/A	N/A	N/A
BLTE	BELITE BIO INC	$3.71B	-30.60%	-29.30%	-24.72%	-60.90%	0.04	24.31	N/A	N/A	N/A
IFRX	INFLARX NV	$91.46M	-68.50%	-53.20%	-86.90%	-104.20%	0.44	3.33	-8,223.10%	-63,818.90%	-63,757.59%
CLNN	CLENE INC	$85.12M	N/A	-111.70%	-184.73%	-112.90%	-3.59	1.58	80.40%	-10,386.40%	-9,398.60%
TELO	TELOMIR PHARMACEUTICALS INC	$46.41M	-566.60%	-447.90%	-161.29%	2,487.30%	0.06	17.51	N/A	N/A	N/A
OCUL	OCULAR THERAPEUTIX INC	$2.41B	-87.20%	-57.90%	-65.70%	-252.50%	0.59	7.85	88.90%	-447.60%	-425.87%
NTLA	INTELLIA THERAPEUTICS INC	$1.01B	-57.20%	-44.60%	-53.61%	-51.60%	0.24	6.21	100.00%	-774.90%	-774.94%
BCYC	BICYCLE THERAPEUTICS PLC	$449.50M	-35.50%	-29.20%	-36.37%	-763.20%	0.24	10.66	100.00%	-884.50%	-891.54%
LITS	LITE STRATEGY INC	$72.02M	-76.40%	-69.90%	-94.18%	-446.80%	0.08	13.50	N/A	N/A	N/A
BFLY	BUTTERFLY NETWORK INC	$535.52M	-37.80%	-27.10%	-32.76%	-62.80%	0.42	4.80	43.20%	-90.30%	-88.76%
RCUS	ARCUS BIOSCIENCES INC	$2.17B	-68.20%	-31.30%	-44.93%	-44.90%	1.23	3.65	100.00%	-142.10%	-138.33%
DBVT	DBV TECHNOLOGIES SA	$447.81M	-295.60%	-135.20%	-204.90%	-4,670.60%	1.09	1.80	100.00%	-2,273.90%	-2,271.65%
IMNM	IMMUNOME INC	$1.57B	-87.20%	-75.60%	-83.13%	-373.20%	0.13	8.90	100.00%	-2,301.30%	-2,301.30%
INDP	INDAPTUS THERAPEUTICS INC	$4.40M	-697.20%	-255.30%	-366.23%	1,274.20%	0.49	2.88	N/A	N/A	N/A
NRXP	NRX PHARMACEUTICALS INC	$49.07M	N/A	-658.10%	94.89%	181.50%	-1.14	0.11	N/A	N/A	N/A
RGNX	REGENXBIO INC	$582.67M	-78.30%	-34.50%	-33.89%	-26.00%	2.25	2.67	87.20%	-110.30%	-84.16%
OSCR	OSCAR HEALTH INC	$3.67B	-21.60%	-4.30%	-12.09%	151.20%	4.61	0.95	16.20%	-2.20%	-1.89%
CLOV	CLOVER HEALTH INVESTMENTS CORP	$1.28B	-17.10%	-10.10%	-15.93%	-31.80%	0.64	1.71	21.20%	-3.30%	-3.29%
ALLO	ALLOGENE THERAPEUTICS INC	$276.42M	-57.80%	-43.10%	-51.66%	-53.00%	0.40	8.19	N/A	N/A	N/A
MIST	MILESTONE PHARMACEUTICALS INC	$170.34M	-2,372.70%	-85.10%	-70.24%	-73.30%	3.28	8.24	N/A	N/A	N/A
IRD	OPUS GENETICS INC	$129.65M	-774.20%	-170.70%	-968.51%	467.50%	5.05	1.24	100.00%	-466.10%	-465.63%
ARAY	ACCURAY INC	$117.87M	-32.10%	-4.10%	0.50%	0.40%	6.38	1.56	30.80%	-4.30%	0.29%
HCTI	HEALTHCARE TRIANGLE INC	$15.18M	-112.80%	-60.00%	-50.36%	-290.90%	0.59	2.03	13.10%	-48.90%	-38.63%
EWTX	EDGEWISE THERAPEUTICS INC	$2.41B	-30.90%	-29.40%	-27.99%	-33.30%	0.04	26.51	N/A	N/A	N/A
BNTC	BENITEC BIOPHARMA INC	$445.63M	-45.90%	-44.00%	-41.64%	2,647.30%	0.03	46.95	N/A	N/A	N/A
ACRV	ACRIVON THERAPEUTICS INC	$70.68M	-53.70%	-48.30%	-62.69%	-69.00%	0.13	8.75	N/A	N/A	N/A
SPRB	SPRUCE BIOSCIENCES INC	$135.94M	-305.40%	-168.00%	-762.62%	955.90%	1.84	1.54	100.00%	-6,869.30%	-6,440.17%
NVAX	NOVAVAX INC	$1.13B	-167.00%	25.50%	50.00%	71.10%	-8.53	2.27	91.80%	32.10%	35.22%
CGEM	CULLINAN THERAPEUTICS INC	$505.10M	-42.10%	-39.80%	-48.01%	-49.30%	0.07	10.45	N/A	N/A	N/A
TLSI	TRISALUS LIFE SCIENCES INC	$227.84M	N/A	-214.90%	-134.68%	-97.00%	-2.36	3.06	84.00%	-174.20%	-85.60%
TVRD	TVARDI THERAPEUTICS INC	$37.81M	-115.90%	-33.70%	-31.65%	-30.90%	0.40	3.48	100.00%	-346.50%	-220.05%
ABCL	ABCELLERA BIOLOGICS INC	$1.10B	-17.00%	-12.60%	-15.92%	-17.70%	0.41	10.10	100.00%	-486.00%	-580.13%
SABS	SAB BIOTHERAPEUTICS INC	$154.25M	33.40%	25.30%	11.00%	32.60%	0.11	10.50	100.00%	16,338.30%	16,554.61%
HSDT	HELIUS MEDICAL TECHNOLOGIES INC	$5.19M	-699.90%	-415.20%	-339.14%	-6,223.70%	0.31	4.32	-89.20%	-7,215.30%	-6,998.98%
GTBP	GT BIOPHARMA INC	$3.28M	-1,643.00%	-182.50%	-195.04%	267.10%	1.49	3.09	N/A	N/A	N/A
ACET	ADICET BIO INC	$101.46M	-77.90%	-64.30%	-94.62%	-84.00%	0.29	5.62	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	623	+2.20%	+5.71%	+6.50%	-48.18%	280.44x	5.12x	-28.91%	-10.34%	-18.67%	+51.40%	Strong Buy
Diagnostics & Research	57	-0.54%	-0.05%	+7.81%	+13.10%	24.30x	4.32x	-0.69%	+6.67%	+14.18%	+6.65%	Strong Buy
Drug Manufacturers - General	20	+0.07%	+7.27%	+13.49%	+21.54%	46.21x	6.69x	+109.31%	+12.14%	+20.15%	+1.52%	Hold
Drug Manufacturers - Specialty & Generic	77	+0.26%	+0.39%	-1.67%	-13.53%	25.64x	2.17x	+10.61%	+3.75%	+7.10%	+39.12%	Strong Buy
Healthcare Plans	10	-1.12%	-1.70%	-11.49%	-30.09%	43.50x	1.99x	+12.29%	+3.80%	+9.27%	+22.65%	Buy
Health Information Services	55	-0.49%	-3.70%	-3.58%	-54.29%	41.06x	4.01x	+7.76%	+4.89%	+7.21%	+35.44%	Strong Buy
Medical Care Facilities	48	-0.85%	-1.86%	+0.24%	-21.33%	14.89x	5.29x	-83.73%	+7.67%	+16.73%	+20.32%	Buy
Medical Devices	138	-0.60%	+2.09%	+2.40%	-33.58%	26.64x	3.95x	+12.09%	+7.33%	+8.47%	+25.75%	Strong Buy
Medical Distribution	11	-0.70%	-0.56%	+11.83%	+39.03%	30.11x	433.03x	-34.73%	+3.63%	+22.01%	+4.72%	Buy
Medical Instruments & Supplies	56	-1.36%	-0.06%	+3.18%	-38.36%	198.50x	3.64x	+10.92%	+8.99%	+11.88%	+19.69%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Nov 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE:MD) is the #1 top healthcare stock out of 1095 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 39, which is 13 points higher than the healthcare sector average of 26. It passed 12 out of 33 due diligence checks and has average fundamentals. Pediatrix Medical Group has seen its stock return 56.84% over the past year, overperforming other healthcare stocks by 89 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -7.85% from Pediatrix Medical Group's current stock price of $23.15.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical (NASDAQ:COLL) is the #2 top healthcare stock out of 1095 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Collegium Pharmaceutical (NASDAQ:COLL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: B.

Collegium Pharmaceutical (NASDAQ:COLL) has a Due Diligence Score of 50, which is 24 points higher than the healthcare sector average of 26. It passed 17 out of 33 due diligence checks and has strong fundamentals. Collegium Pharmaceutical has seen its stock return 51.9% over the past year, overperforming other healthcare stocks by 84 percentage points.

Collegium Pharmaceutical has an average 1 year price target of $46.67, an upside of 1.49% from Collegium Pharmaceutical's current stock price of $45.98.

Collegium Pharmaceutical stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Collegium Pharmaceutical, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior (NASDAQ:INDV)

Indivior (NASDAQ:INDV) is the #3 top healthcare stock out of 1095 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: C.

Indivior (NASDAQ:INDV) has a Due Diligence Score of 27, which is 1 points higher than the healthcare sector average of 26. It passed 8 out of 33 due diligence checks and has average fundamentals. Indivior has seen its stock return 200.39% over the past year, overperforming other healthcare stocks by 232 percentage points.

Indivior has an average 1 year price target of $32.50, an upside of 6.59% from Indivior's current stock price of $30.49.

Indivior stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Indivior, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 13.09%, which is 11 percentage points higher than the healthcare sector average of 2.04%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 36% indicates that its high dividend yield is sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 10.84%, which is 9 percentage points higher than the healthcare sector average of 2.04%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.99%, which is 7 percentage points higher than the healthcare sector average of 2.04%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.35% in the last day, and up 2.29% over the last week. Leap Therapeutics was the among the top gainers in the healthcare sector, gaining 368.04% yesterday.

Leap Therapeutics shares are trading higher after the company reported better-than-expected Q3 EPS results.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 3.12% in the past year. It has overperformed other stocks in the healthcare sector by 35 percentage points.

2. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -50.82% in the past year. It has underperformed other stocks in the healthcare sector by -19 percentage points.

3. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -28.31% in the past year. It has overperformed other stocks in the healthcare sector by 4 percentage points.

Are healthcare stocks a good buy now?

54.66% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 28.56% over the next year.

8.08% of healthcare stocks have a Zen Rating of A (Strong Buy), 10.89% of healthcare stocks are rated B (Buy), 46.72% are rated C (Hold), 24.47% are rated D (Sell), and 9.84% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 84.32x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Collegium Pharmaceutical (NASDAQ:COLL)

3. Indivior (NASDAQ:INDV)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Organon & Co (NYSE:OGN)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Collegium Pharmaceutical (NASDAQ:COLL)

3. Indivior (NASDAQ:INDV)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Organon & Co (NYSE:OGN)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.